| Oncosil Medical Limited (OSL) ORDINARY FULLY PAID |
Health Care |
$14 |
Investor Webinar Invitation
|
7 Aug 2025 10:06AM |
$1.085 |
$0.450 |
fallen by
58.53%
|
|
| WT Financial Group Limited (WTL) ORDINARY FULLY PAID |
Financials |
$44 |
INVESTOR BRIEFING PRESENTATION DECK
|
7 Aug 2025 10:05AM |
$0.145 |
$0.130 |
fallen by
10.34%
|
|
WTL - Price-sensitive ASX Announcement
Full Release
Key Points
- WTL is a top three, non-institutionally owned financial advice group in Australia.
- The group serves over 150,000 retail clients via more than 500 advisers in 250 locations.
- WTL’s business model centers on providing licensee services, advice, and product solutions to financial advisers and their clients.
- Recent acquisitions, including Synchron, Sentry Group, and Wealth Today, have expanded WTL’s scale and capability.
- The company has achieved significant improvements in underlying EBITDA, revenue, and net operating cash flow.
- Strong focus on integration, cost management, and operational efficiency boosts profitability.
- WTL maintains a diversified network of advisers and clients, reducing business concentration risk.
- The company is positioned to benefit from industry consolidation and increasing demand for professional financial advice.
- WTL’s management team is experienced and aligned with shareholders, holding a significant equity stake.
- Capital management policy supports shareholder returns, with intentions to pay dividends subject to performance and regulatory requirements.
- Outlook remains positive with continued focus on organic growth, strategic acquisitions, and delivering value to clients and shareholders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Trigg Minerals Limited (TMG) ORDINARY FULLY PAID |
Materials |
- |
Response to ASX Price and Volume Query
|
7 Aug 2025 10:01AM |
$0.110 |
$0.120 |
risen by
9.09%
|
|
TMG - Price-sensitive ASX Announcement
Full Release
Key Points
- Trigg Minerals Limited received an ASX query regarding increased share price and trading volumes.
- TMG responded that it is not aware of any information that could explain the trading activity, except for previously released announcements.
- The company confirmed it remains in compliance with Listing Rule 3.1 and its continuous disclosure obligations.
- TMG has no undisclosed information regarding its financial position or operations.
- The response emphasizes the company’s ongoing commitment to transparency and regulatory requirements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Strategic Energy Resources Limited (SER) ORDINARY FULLY PAID |
Materials |
$12 |
Section 708A Cleansing Statement
|
7 Aug 2025 10:01AM |
$0.006 |
$0.220 |
risen by
3,566.67%
|
|
| Trigg Minerals Limited (TMG) ORDINARY FULLY PAID |
Materials |
- |
Proposed issue of securities - TMG
|
7 Aug 2025 10:01AM |
$0.110 |
$0.120 |
risen by
9.09%
|
|
| Trigg Minerals Limited (TMG) ORDINARY FULLY PAID |
Materials |
- |
Strategic Critical Mineral Expansion into Tungsten
|
7 Aug 2025 10:01AM |
$0.110 |
$0.120 |
risen by
9.09%
|
|
TMG - Price-sensitive ASX Announcement
Full Release
Key Points
- TMG has acquired an advanced tungsten project in Western Australia, marking its entry into the critical minerals sector.
- Tungsten is identified as a critical mineral due to its essential industrial uses and potential supply risk.
- The acquisition supports TMG’s strategy to diversify beyond its core sulphate of potash business.
- Global demand and supply chain risks for tungsten are highlighted as key drivers for the strategic move.
- TMG’s management emphasizes the project’s strong geological potential and strategic value.
- The company aims to leverage its mineral development expertise to advance the new tungsten project.
- This expansion is intended to position TMG as a significant contributor to the critical minerals value chain in Australia.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Forrestania Resources Limited (FRS) ORDINARY FULLY PAID |
Materials |
$781 |
Change in substantial holding
|
7 Aug 2025 10:00AM |
$0.190 |
$0.605 |
risen by
218.42%
|
|
| Adslot Ltd (ADS) ORDINARY FULLY PAID |
Information Technology |
$6 |
Proposed issue of securities - ADS
|
7 Aug 2025 10:00AM |
$0.001 |
$0.001 |
fallen by
0%
|
|
| 360 Capital Mortgage REIT (TCF) ORDINARY UNITS FULLY PAID |
Financials |
$52 |
Appendix 4G
|
7 Aug 2025 9:58AM |
$6.010 |
$5.780 |
fallen by
3.83%
|
|
| Strategic Energy Resources Limited (SER) ORDINARY FULLY PAID |
Materials |
$12 |
Application for quotation of securities - SER
|
7 Aug 2025 9:57AM |
$0.006 |
$0.220 |
risen by
3,566.67%
|
|
| White Cliff Minerals Limited (WCN) ORDINARY FULLY PAID |
Materials |
$45 |
Appendix 3Y - John Hancock
|
7 Aug 2025 9:54AM |
$0.023 |
$0.017 |
fallen by
26.09%
|
|
| Gemlife Communities Group (GLF) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$1,715 |
Date of release of FY25 half year results & briefing details
|
7 Aug 2025 9:52AM |
$4.420 |
$4.510 |
risen by
2.04%
|
|
| Liontown Limited (LTR) ORDINARY FULLY PAID |
Materials |
$7,471 |
Proposed issue of securities - LTR
|
7 Aug 2025 9:52AM |
$0.845 |
$2.350 |
risen by
178.11%
|
|
| 360 Capital Mortgage REIT (TCF) ORDINARY UNITS FULLY PAID |
Financials |
$52 |
FY25 Results Presentation
|
7 Aug 2025 9:51AM |
$6.010 |
$5.780 |
fallen by
3.83%
|
|
| Adslot Ltd (ADS) ORDINARY FULLY PAID |
Information Technology |
$6 |
Cleansing Notice - Convertible Notes
|
7 Aug 2025 9:51AM |
$0.001 |
$0.001 |
fallen by
0%
|
|
| Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID |
Health Care |
$1,617 |
DAYBUE Q2 2025 net sales US$96.1 million up 14% from Q2 2024
|
7 Aug 2025 9:51AM |
$17.010 |
$12.790 |
fallen by
24.81%
|
|
NEU - Price-sensitive ASX Announcement
Full Release
Key Points
- Q2 2025 DAYBUE™ (trofinetide) net sales were US$96.1 million, up 14% from Q2 2024.
- Neuren Pharmaceuticals earned royalty income of A$14.7 million in Q2 2025.
- Acadia Pharmaceuticals completed expansion of its DAYBUE sales force to boost growth.
- Acadia's full year 2025 US net sales guidance for DAYBUE is US$380 - 405 million.
- European commercial team is being built by Acadia in anticipation of approval in Q1 2026.
- Named patient supply programs initiated in Europe, Israel, and the Rest of the World.
- DAYBUE's persistency rate remains steady above 50% after 12 months of treatment.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID |
Health Care |
$1,617 |
DAYBUE Q2 2025 net sales US$96.1 million up 14% from Q2 2024
|
7 Aug 2025 9:51AM |
$17.010 |
$12.790 |
fallen by
24.81%
|
|
NEU - Price-sensitive ASX Announcement
Full Release
Key Points
- DAYBUE Q2 2025 net sales reached US$96.1 million, up 14% from Q2 2024.
- Neuren Pharmaceuticals earned Q2 2025 royalty income of A$14.7 million.
- Acadia Pharmaceuticals completed planned expansion of DAYBUE sales force.
- Acadia reiterated full year 2025 DAYBUE US net sales guidance of US$380 - 405 million.
- Record number of patients in the US received DAYBUE shipments.
- Acadia initiated named patient supply programs in Europe and Rest of the World.
- Substantial potential for future growth in the US with many Rett patients yet to try DAYBUE.
- Neuren's programs have orphan drug designation in the United States.
- DAYBUE is approved by the US FDA and Health Canada for treating Rett syndrome.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Adslot Ltd (ADS) ORDINARY FULLY PAID |
Information Technology |
$6 |
Proposed issue of securities - ADS
|
7 Aug 2025 9:51AM |
$0.001 |
$0.001 |
fallen by
0%
|
|
| 360 Capital Mortgage REIT (TCF) ORDINARY UNITS FULLY PAID |
Financials |
$52 |
FY25 Results Announcement
|
7 Aug 2025 9:50AM |
$6.010 |
$5.780 |
fallen by
3.83%
|
|
| 360 Capital Mortgage REIT (TCF) ORDINARY UNITS FULLY PAID |
Financials |
$52 |
FY25 Appendix 4E and Annual Report
|
7 Aug 2025 9:49AM |
$6.010 |
$5.780 |
fallen by
3.83%
|
|
| Findi Limited (FND) ORDINARY FULLY PAID |
Financials |
$67 |
Proposed issue of securities - FND
|
7 Aug 2025 9:49AM |
$3.790 |
$0.675 |
fallen by
82.19%
|
|
| IRIS Metals Limited (IR1) ORDINARY FULLY PAID |
Materials |
$18 |
Application for quotation of securities - IR1
|
7 Aug 2025 9:48AM |
$0.079 |
$0.064 |
fallen by
18.47%
|
|
| Classic Minerals Limited (CLZ) ORDINARY FULLY PAID |
Materials |
$6 |
Classic Advances Scale Up Strategy With 250ktpa Plant
|
7 Aug 2025 9:48AM |
$0.001 |
$0.001 |
fallen by
0%
|
|
| Warriedar Resources Limited (WA8) ORDINARY FULLY PAID |
Materials |
- |
Appointment of Independent Expert
|
7 Aug 2025 9:45AM |
$0.155 |
$0.265 |
risen by
70.97%
|
|
| Findi Limited (FND) ORDINARY FULLY PAID |
Financials |
$67 |
Findi undertakes $9.5 million Loan Note raising
|
7 Aug 2025 9:45AM |
$3.790 |
$0.675 |
fallen by
82.19%
|
|
FND - Price-sensitive ASX Announcement
Full Release
Key Points
- Findi Limited is raising $9.5 million via unsecured redeemable loan notes.
- Funds will be used to repay existing working capital facility and for additional working capital needs.
- The raising supports ongoing growth of Indian subsidiary TSI India.
- Loan Notes carry a 10% per annum interest rate, maturing no later than 30 September 2026.
- The issue is targeted at sophisticated and professional investors.
- Board believes the raising will enable further expansion in the Indian ATM and payments market.
- Raising strengthens Findi Limited’s balance sheet and improves financial flexibility.
- Loan Notes are expected to be issued in two tranches.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
